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ABSTRACT In Gram-negative bacteria, lipopolysaccharide (LPS) contributes to the ro-
bust permeability barrier of the outer membrane (OM), preventing the entry of toxic
molecules, such as detergents and antibiotics. LPS is transported from the inner mem-
brane (IM) to the OM by the Lpt multiprotein machinery. Defects in LPS transport com-
promise LPS assembly at the OM and result in increased antibiotic sensitivity. LptA is a
key component of the Lpt machine that interacts with the IM protein LptC and chaper-
ones LPS through the periplasm. We report here the construction of lptA41, a quadruple
mutant in four conserved amino acids potentially involved in LPS or LptC binding. Al-
though viable, the mutant displays increased sensitivity to several antibiotics (bacitracin,
rifampin, and novobiocin) and the detergent SDS, suggesting that lptA41 affects LPS
transport. Indeed, lptA41 is defective in Lpt complex assembly, and its lipid A carries
modiﬁcations diagnostic of LPS transport defects. We also selected and characterized
two phenotypic bacitracin-resistant suppressors of lptA41. One mutant, in which only
bacitracin sensitivity is suppressed, harbors a small in-frame deletion in mlaA, which
codes for an OM lipoprotein involved in maintaining OM asymmetry by reducing accu-
mulation of phospholipids in the outer leaﬂet. The other mutant, in which bacitracin, ri-
fampin, and SDS sensitivity is suppressed, harbors an additional amino acid substitution
in LptA41 and a nonsense mutation in opgH, encoding a glycosyltransferase involved in
periplasmic membrane-derived oligosaccharide synthesis. Characterization of the sup-
pressor mutants highlights different strategies adopted by the cell to overcome OM de-
fects caused by impaired LPS transport.
IMPORTANCE Lipopolysaccharide (LPS) is the major constituent of the outer mem-
brane (OM) of most Gram-negative bacteria, forming a barrier against antibiotics.
LPS is synthesized at the inner membrane (IM), transported across the periplasm,
and assembled at the OM by the multiprotein Lpt complex. LptA is the periplasmic
component of the Lpt complex, which bridges IM and OM and ferries LPS across the
periplasm. How the cell coordinates the processes involved in OM biogenesis is not
completely understood. We generated a mutant partially defective in lptA that ex-
hibited increased sensitivity to antibiotics and selected for suppressors of the mu-
tant. The analysis of two independent suppressors revealed different strategies ad-
opted by the cell to overcome defects in LPS biogenesis.
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Gram-negative bacteria are characterized by a cell envelope composed of twoconcentric membranes, the inner membrane (IM) and the outer membrane (OM),
separated by a hydrophilic compartment, the periplasm, in which the murein wall is
embedded (1, 2). The two membranes have different compositions and permeability
properties. While the IM is a typical phospholipid (PL) bilayer, the OM is an asymmetric
bilayer with PLs and lipopolysaccharides (LPS) in the inner and outer leaﬂet, respec-
tively. LPS is a negatively charged amphipathic molecule composed of three covalently
linked moieties: lipid A, a core oligosaccharide, and a long polysaccharide called O
antigen (Fig. 1A) (3). In the presence of divalent cations, LPS molecules pack tightly
together to form a layer that reduces OM ﬂuidity and permeability, which is selectively
controlled by dedicated OM proteins (4). LPS organization can be disrupted by defects
in OM component assembly (5), in mutants producing LPS with truncated sugar chains
(6), or by exposure to antimicrobial peptides and chelating agents, such as EDTA, which
displace divalent cations between LPS molecules (4). Perturbation of LPS organization
on the cell surface induces PL migration from the inner to the outer leaﬂet of the OM,
generating locally symmetrical bilayer rafts that are more permeable to hydrophobic
molecules (4). Cells have evolved systems to monitor the integrity of the OM and to
respond to disruption of OM asymmetry either by removing PLs from the outer leaﬂet
or by modifying LPS. Outer membrane phospholipase A (OMPLA), encoded by pldA, is
an OM phospholipase that degrades PLs that have accumulated in the outer leaﬂet of
the OM (7). PagP is an OM acyltransferase that transfers a palmitate acyl chain from PLs
in the outer leaﬂet to lipid A (8) and to phosphatidylglycerol (9). A third system, the Mla
(maintenance of OM lipid asymmetry) complex, prevents PL accumulation in the outer
leaﬂet of the OM. The Mla system comprises at least six proteins distributed across the
cell envelope. MlaA (formerly VacJ) is a predicted OM lipoprotein, MlaC is a periplasmic
protein, and MlaFEDB form a putative ABC transporter at the IM (10, 11). Mutations in
the Mla system are not lethal but lead to PL accumulation in the outer leaﬂet of the OM
and result in increased sensitivity to sodium dodecyl sulfate (SDS) (10). Recently, MlaA
has been found to interact speciﬁcally with the OM -barrel OmpC (12). Notably, cells
lacking OmpC accumulate PLs in the outer leaﬂet of the OM in stationary phase, thus
implicating OmpC in the maintenance of lipid asymmetry and suggesting OmpC as an
additional OM component of the Mla system (12). The mechanism of Mla complex-
mediated retrograde PL transport is not yet completely clear, and nothing is known
about the anterograde trafﬁcking of PLs from the IM to the OM. Interestingly, recent
work has revealed that two additional proteins with unknown functions, belonging to
the same mammalian cell entry (MCE) protein family as MlaD, form transenvelope
structures in the periplasm (13). This suggests that much remains to be understood
about lipid trafﬁcking between membranes in Gram-negative bacteria and highlights
the relevance of multiprotein complexes in OM biogenesis.
The asymmetric distribution of LPS in the OM is generated by the Lpt system, a
molecular machine that transports and assembles LPS exclusively in the outer leaﬂet of
the membrane. In Escherichia coli, the Lpt machinery is composed of seven essential
proteins (LptABCDEFG) that span the entire envelope (14–18) (Fig. 1B). This multipro-
tein machinery is organized into two subassemblies (19, 20). At the IM, the ABC
transporter LptB2FG, associated with the bitopic protein LptC, energizes the system
(21). At the OM, the -barrel LptD protein and the lipoprotein LptE constitute the OM
translocon, characterized by a peculiar plug-and-barrel architecture (22–26), which is
responsible for the ﬁnal stages of LPS assembly at the cell surface. LptA, which connects
the IM LptB2FGC and the OM LptDE subcomplexes, receives the LPS from LptC in an
energy-dependent process and is thought to deliver it to the LptDE complex for
insertion in the outer leaﬂet of the OM (21). The crystal structures of LptA from E. coli
and of the LptH homologue from Pseudomonas aeruginosa have been solved (27, 28).
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LptA and LptH display very similar -jellyroll folds, despite very low sequence similarity.
Notably, a very similar -jellyroll architecture is also present in the periplasmic region
of LptC, in the periplasmic domains of LptF and LptG, and in the N-terminal domain of
LptD proteins from several organisms (25, 29–31). It thus appears that the presence of
such an “Lpt fold” is crucial for the assembly of a functional Lpt machine in which the
C terminus of LptC interacts with the N terminus of LptA and the C terminus of LptA
interacts with the N terminus of LptD (32, 33). These proteins therefore constitute the
protein bridge that connects the IM and the OM and build up a hydrophobic groove
able to accommodate the lipid moiety of LPS during its journey across the periplasm
(19).
LptA is a key component of the protein bridge; nevertheless, it is still not well
understood how the protein interacts with its LptC and LptD partners and with the LPS
ligand. LptA undergoes oligomerization in vitro (27, 34, 35), yet it is not known whether
it functions as an oligomer in the Lpt machine or how many LptA molecules form the
protein bridge that connects the IM and OM. Photo-cross-linking experiments have
highlighted a few amino acids implicated in LptA-LptC or LptA-LptA (H37) and LptA-
LptD (V163) interactions (32) and several residues implicated in LptA-LPS binding (I36,
F95, T32, Y114, and L116) (21). However, replacements of none of these amino acids
have been shown to impair LptA function in vivo (21, 27). Only two inactive E. coli LptA
mutants, Q111P (36) and G138R (28), which have not been extensively characterized,
have been reported so far.
In an effort to extend the LptA structure-function relationship, we report here the
characterization of a viable quadruple lptA mutant that is impaired in the assembly of
the Lpt machinery, although it retains the ability to bind LPS. Although viable, the
FIG 1 LPS transport system. (A) Chemical structure of LPS. The lipid A and core structures depicted correspond to those of E. coli K-12. The O antigen, if
present, is highly variable. Gal, D-galactose; Glc, D-glucose; Hep, L-glycero-D-manno-heptose; KDO, 2-keto-3-deoxy-octonic acid; EtN, ethanolamine; P,
phosphate. (B) Transport of LPS from IM to OM. After ﬂipping over the IM by MsbA protein, LPS is transported across the periplasm and assembled at the
cell surface by the Lpt machinery. (C) Graphic representation of the crystal structure of E. coli LptA (Protein Data Bank [PDB] 2r19, chain B). Residues involved
in LptC interaction according to reference 55 (I38, E39, S40, Q42, and Q43) are represented by red spheres; residues involved in LPS interaction according
to reference 21 (T32, F95, Y114, and L116) are represented by blue spheres. Residue I36 is involved in both LPS and LptC interactions and is represented
in pink.
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quadruple lptA mutant disrupts OM asymmetry and severely impairs the OM permea-
bility barrier. Suppressor mutants that partially reverse the OM permeability defects
provide insights into the strategies adopted by cells to restore OM functionality.
RESULTS
Generation of a quadruple lptA mutant. Several conserved amino acid residues
located at the N-terminal rim of the LptA protein, namely, I36, I38, R76, and K83 (Fig.
2A), have been previously postulated to be important for its functionality (27). Indeed,
I36 has been implicated in LPS binding (21) and LptA oligomerization (35). Three of the
residues (I36, I38, and R76) had been previously mutated individually to both D and E
without an appreciable phenotype, as site-speciﬁc single mutations in any of these
residues do not impair LptA function (27).
We thus tested whether multiple mutations (in the lptA41 allele, encoding the
following amino acid substitutions: I36A, I38A, R76D, and K83D) could impair LptA
functionality. Since both lptA and lptB are essential genes, we introduced pWSK29-
LptA41 LptB, a low-copy-number plasmid expressing the lptA41-lptB operon, into
FL907, a conditional expression mutant in which the lptAB operon is inducible by
arabinose (16). We observed that this strain could grow both in the presence and in the
absence of arabinose, and thus the lptA41 allele is viable.
Partial impairment of LPS transport, albeit nonlethal, may be associated with
increased OM permeability to hydrophobic toxic compounds and detergents (2). To
test whether lptA41 is a partial loss-of-function allele, plasmid pWSK29-LptA41 LptB was
introduced into the reference wild-type strain AM604, and the chromosomal lptAB
operon was replaced with the ΔlptAB::kan allele, generating the lptA41 mutant strain
PS003, in which deletion of the lptAB operon is complemented. The OM permeability
of PS003 was probed by testing its sensitivity to a panel of hydrophobic (novobiocin
[Nov] and rifampin [Rif]) and hydrophilic (bacitracin [Bct]) antibiotics. As a control, the
isogenic strain PS001, in which the ΔlptAB::kan allele is complemented by plasmid
FIG 2 LptA41 mutations and lptA41 suppressor phenotypes. (A) Ribbon diagram of E. coli LptA. Residues
mutated by site-directed mutagenesis (I36, I38, R76, and K83) are indicated in red. The intragenic
suppressor (lptA42 quintuple-mutant allele) encodes an additional amino acid change at the position
indicated in green (M112). (B) OM permeability assay of the lptA41 strain and suppressor mutants. Serial
10-fold dilutions of stationary-phase cultures of AM604 (wild-type reference strain); PS001 (wild-type lptA
control strain ectopically expressing lptAB); PS003 (ectopically expressing lptA41 lptB); and PS101, PS102,
and PS103 (PS003 derivative suppressor mutants) were replicated on LD (for AM604) or LD-ampicillin
agar plates supplemented with bacitracin (50 g/ml), novobiocin (10 g/ml), and rifampin (2.5 g/ml),
as indicated. (C) Cell lysates from AM604, PS001, PS003, PS101, PS102, and PS103 were analyzed by
Western blotting with anti-LptA and anti-LPS antibodies as described in Materials and Methods. Culture
samples with equal OD600 values were processed and loaded into each lane. The different electrophoretic
mobility of LptA41 relative to LptA can be explained by the different net charge of the mutant protein.
A nonspeciﬁc band was used as a loading control (LC).
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pWSK29-LptA LptB expressing wild-type LptA, was used. As shown in Fig. 2B, the lptA41
mutant displayed increased sensitivity to the antibiotics tested compared to the
isogenic strain expressing wild-type lptA, suggesting that lptA41 is a partial-loss-of-
function allele of lptA.
The lptA41 allele induces modiﬁcations in lipid A. Conditions that disrupt OM
asymmetry, such as defective LPS biogenesis (15, 24) or LPS release from the OM upon
EDTA treatment, result in translocation of PLs to the outer leaﬂet of the OM (37).
Bacteria respond to such stress conditions by activating enzymes that modify the basic
lipid A structure (38). We thus analyzed by matrix-assisted laser desorption ionization–
time of ﬂight mass spectrometry (MALDI-TOF MS) the composition of lipid A extracted
from the ectopically complemented lptA41 (PS003) and lptA (PS001) isogenic strains to
detect lipid A modiﬁcations as a marker of LPS transport defects (39); the parental
reference strain AM604 (wild type), untreated and treated with EDTA, was used as a
control.
As shown in Fig. 3, untreated AM604 and PS001 (both expressing wild-type LptA)
cells (Fig. 3A and C, respectively) did not produce detectable peaks corresponding to
modiﬁed lipid A species. On the other hand, hepta-acylated lipid A mono- and
bis-phosphate species were detected both in the AM604 EDTA-treated and in PS003
(lptA41-complemented) cells (Fig. 3B and D, respectively). Interestingly in the latter
sample, a peak corresponding to phosphoethanolamine (PEtN)-modiﬁed lipid A species
was also detected. This modiﬁcation is catalyzed by the EptA enzyme, which decorates
the phosphate in position 1 by adding a PEtN moiety and is known to be induced in
response to OM perturbation by antimicrobial peptides (38, 39). These data suggest
that the lptA41 allele, although complementing the ΔlptA mutant for viability, leads to
the translocation of PLs in the outer leaﬂet of the OM, a diagnostic trait of LPS transport
defects.
The LptA41 mutant fails to assemble the Lpt complex. We then assessed whether
the defect associated with lptA41 could depend on lower levels or stability of LptA
protein in the cell. As shown in Fig. 2C, the steady-state level of LptA41 was about
3-fold lower than that of the wild-type LptA, as revealed by densitometric analysis of
bands in Western blots with anti-LptA antibodies, suggesting lower stability of the
quadruple-mutant protein. It should be noted, however, that the LptA41 protein
abundance in the complemented ΔlptA mutant was greater than that of the wild-type
LptA expressed from the chromosome (undetectable under our experimental condi-
tions) (Fig. 2C). Thus, the defects caused by the lptA41 allele cannot be solely attributed
to lower abundance of the mutant protein but must involve other functional aspects.
To determine whether LptA41 affects Lpt complex assembly, we performed afﬁnity
puriﬁcation experiments with solubilized membranes of strains AM604, PS001, and
PS003 ectopically expressing C-terminally His-tagged LptC (LptC-H) from plasmid
pGS108. As a negative control, afﬁnity puriﬁcation was carried out from solubilized
membranes of strain AM604 ectopically expressing untagged LptC from plasmid
pGS103. Afﬁnity-puriﬁed samples were then analyzed by SDS-PAGE immunoblotting
with a panel of speciﬁc antibodies. As shown in Fig. 4A, in the LptA41-complemented
strain PS003, LptC-H copuriﬁed LptF and LptB as in the positive controls, AM604 and
PS001, suggesting that the IM LptB2FGC subcomplex was properly assembled. On the
other hand, neither the LptA41 mutant protein nor LptD was enriched in afﬁnity-
puriﬁed membranes from PS003 (Fig. 4A), suggesting that LptA41 cannot interact with
LptC and, therefore, that the OM LptDE complex cannot be properly recruited into the
Lpt complex. It should be noted that the amount of LptC-H puriﬁed from membranes
of the PS003 mutant was slightly lower than that puriﬁed from the control strains
expressing wild-type LptA. However, the amount of LptC-H did not affect the amount
of the inner membrane component LptF in the afﬁnity-puriﬁed membranes, which
appeared to be similar in all the strains. This suggests that the plasmid-encoded LptC-H
protein is expressed in excess relative to the other components of the Lpt complex, and
thus, its level cannot account for the lack of LptA41 copuriﬁcation in the PS003 mutant.
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On the other hand, the lower production of LptA41 from the lptA41 allele cannot
account for the lack of LptA41 copuriﬁcation by LptC-H in strain PS003, since the
steady-state level of chromosomally expressed LptA in AM604 is much lower than those
in strains PS003 and PS001 (Fig. 2C), whereas the amount of LptA copuriﬁed with
LptC-H from AM604 is comparable to that in PS001. These observations suggest that
the absence of LptA signal in the lane corresponding to the PS003 sample is evidence
of impaired Lpt complex assembly in the lptA41 mutant.
LptA and LptC directly interact with LPS, and some residues involved in this
interaction have been identiﬁed by photo-cross-linking experiments; one such residue
is LptAI36, which is mutated in LptA41 (21). Therefore, we performed an in vitro LPS
binding assay using puriﬁed C-terminally His-tagged LptA and LptA41 proteins (LptA-H
and LptA41-H, respectively) and smooth-type LPS (34, 40). It should be noted that the
LptA-H construct is functional, as when coexpressed with LptB, it complemented the
FIG 3 Lipid A modiﬁcations in lptA41 suppressor strains. MALDI-TOF proﬁles of lipid A isolated from wild-type strain AM604 (A and B) treated (B) or not treated
(A) with EDTA, PS001 (lptA) (C), PS003 (lptA41) (D), and suppressor strains PS102 (mlaA102) (E) and PS103 (lptA42/opgH103) (F). The percent intensity relative
to the most abundant species for each peak is reported. The inset plots show 10-fold-magniﬁed views of the region around m/z 1,800 to 2,050. Relevant lipid
A species are indicated. For details, see Materials and Methods.
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lptAB conditional-expression mutant under nonpermissive conditions (data not shown).
As shown in Fig. 4B, LptA41 retains the ability to interact with LPS.
Overall, these data suggest that the phenotype associated with the lptA41 allele is
due to defects in Lpt complex assembly and not in LPS binding.
Screen for suppressors of the lptA41 increased antibiotic susceptibility pheno-
type. Analysis of suppressor mutants is a powerful tool to identify genetic and
functional interactions between the gene of interest and other genes in the same or
different pathways (41). We therefore selected for spontaneous phenotypic revertants
to bacitracin resistance by plating independent cultures of the lptA41 mutant on
low-salt LB medium (LD medium) supplemented with 0.15 g/ml bacitracin, a lethal
concentration for the lptA41 strain but not for the wild type.
Fifteen independent bacitracin-resistant mutants, which arose at a frequency of
approximately 108, were colony puriﬁed and tested for sensitivity to bacitracin,
novobiocin, and rifampin. None of the mutants fully reverted to the wild-type pheno-
type (Fig. 2B). Based on their sensitivity proﬁles, the mutants could be grouped in three
classes, and a representative of each class (strains PS101, PS102, and PS103) was chosen
for subsequent analysis. PS102 retained sensitivity to novobiocin, rifampin, and SDS-
EDTA, suggesting that suppression was acting on a pathway speciﬁc for bacitracin
FIG 4 Lpt complex assembly and LPS binding by LptA mutants. (A) Assembly of wild-type and mutant LptA
proteins into the Lpt complex. Total membranes were collected from strains AM604 expressing chromosomal
LptA [LptA (c)], PS001 ectopically expressing LptA [LptA (p)], PS003 ectopically expressing LptA41 [LptA41 (p)],
PS111 ectopically expressing LptA42 [LptA42 (p)] harboring pGS108 expressing His-tagged LptC (LptC-H), or
pGS103 expressing the nontagged LptC (LptC) as a negative control. Samples were solubilized with DDM and
afﬁnity puriﬁed using a Talon metal afﬁnity resin. The proteins were then fractionated by SDS-PAGE, and
immunoblotting was performed with anti-LptD, anti-LptF, anti-LptB, and anti-His (to detect LptC-H) antibod-
ies. For LptA detection, samples were analyzed by Tricine SDS-PAGE, and immunoblotting was performed
using anti-LptA antibody. The asterisks indicate degradation products of LptA. (B) Binding of wild-type and
mutant LptA proteins to LPS. The abilities of His-tagged LptA, LptA41, and LptA42 to bind puriﬁed LPS were
assessed by their coelution fromNi-NTA chromatography resin. LPS and the puriﬁed His-tagged proteins were
incubated and afﬁnity puriﬁed on Ni-NTA resin as described in Materials and Methods. As a negative control,
LPS was incubated without any added protein (none). FT, ﬂowthrough; E1 and E2, elutions. To monitor
LPS-LptA complex formation, equal volumes of the collected chromatographic fractions were analyzed by
denaturing gel electrophoresis. LptA-H protein was detected by SDS-PAGE and Western blotting with anti-His
antibodies; for LPS visualization, samples were analyzed by Tricine SDS-PAGE, and Western blotting was
performed with anti-lipid A core antibodies.
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rather than alleviating the permeability barrier defect associated with lptA41. In addi-
tion to bacitracin, in PS103, resistance to rifampin and SDS-EDTA and partial resistance
to novobiocin were restored, whereas PS101 exhibited resistance only to SDS-EDTA and
partially to novobiocin.
Sequencing the plasmid-borne lptA genes of the three mutants revealed that PS101
and PS102 harbored the lptA41 allele, whereas in PS103, an additional mutation causing
the M112I amino acid substitution was present; the quintuple mutant was designated
lptA42.
Analysis of the LptA steady-state level in the suppressor strains showed that in the
PS101 mutant the steady-state level of LptA41 was highly increased relative to that of
the parental strain, PS003 (lptA41), and this appeared to correlate with a higher copy
number of the complementing plasmid (Fig. 2C). In PS102, the LptA level was similar to
that in the parental strain, PS003, whereas in PS103, the level of LptA appeared to be
intermediate between the wild type and the lptA41 mutant, suggesting that the
additional M112I substitution may to some extent stabilize the mutant protein (Fig. 2C).
To identify potential chromosomally encoded suppressors of the increased antibi-
otic sensitivity, we performed genomic sequencing of the three selected strains. The
total number of reads obtained for each strain allowed us to reach more than 360-fold
mean coverage for the coding portion of each strain’s genome (see Table S1 in the
supplemental material). In order to identify single nucleotide variations (SNVs) or
insertions/deletions (indels) in the coding sequences (CDS), which could be potential
suppressors of the antibiotic sensitivity phenotype, we mapped all the reads obtained
for each of the three suppressor strains and their PS003 parental strain against the
reference genome of MC4100 (parental strain, AM604). PS003 harbored several varia-
tions relative to MC4100, many of which were common to all the suppressor strains and
thus may simply represent mutations accumulated in a different laboratory line. Table
1 reports the mutations in the suppressor strains not shared with the parental strain,
PS003. In our subsequent analysis, we considered neither the variants identiﬁed in lacZ,
a gene largely manipulated in MC4100 (42), nor single nucleotide changes in intergenic
regions relevant.
Analysis of genomic-sequencing results from PS101 did not reveal any mutation that
could be correlated with the suppression and/or the increased complementing plasmid
TABLE 1Mutations in suppressor strains
Strain
Genomic
coordinatea Mutation Gene Product
Gene
coordinatec
Amino acid
changed
PS101 290676 T¡G transversion Intergenic NAb NA NA
4178702 G¡C transversion lacZ -Galactosidase 246 Arg116Gly
4178861 G insertion lacZ -Galactosidase 187 Ser63fs
4178862 A¡G transition lacZ -Galactosidase 186 None
4178862 CGG insertion lacZ -Galactosidase 183 Asp62fs
PS102 290676 T¡G transversion Intergenic NA NA NA
1574918 A insertion tus Replication terminus
site-binding protein
577 Ser193fs
2348710 AAGTTG deletion mlaA Putative lipoprotein 120 ΔAsn41-Phe42
2613172 G¡A transition Intergenic NA NA NA
4178702 G¡C transversion lacZ -Galactosidase 346 Arg116Gly
4178862 A¡G transition lacZ -Galactosidase 186 None
4178862 CG insertion lacZ -Galactosidase 184 Asp62fs
PS103 425601 A¡G transition rhsD rhsD element 358 Ser120Gly
1015255 G¡A transition mdoH Glucosyltransferase 1245 Trp415Stop
3667499 T¡G transversion Intergenic NA NA NA
3228885e G¡T transversion lptA LPS transport protein 336 Met112Ile
aFor deletions and insertions, the coordinate indicates the ﬁrst deleted base and the base after which insertion occurred, respectively.
bNA, not applicable.
cCoordinates from the ﬁrst base of the open reading frame (ORF). For deletions and insertions, the coordinate indicates the ﬁrst deleted amino acid and the amino
acid after which insertion occurred, respectively.
dfs, frameshift starting at the codon indicated.
eThis region is actually harbored by the complementing plasmid.
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copy number and/or LptA41 abundance (Fig. 2C). It is possible that the increased copy
number of the plasmid, and consequently the higher expression level of LptA41,
contributes to the suppression of bacitracin and novobiocin susceptibility. Variations in
nonsequenced regions (gaps) may contribute to suppression and/or increased plasmid
copy numbers. No further analysis was performed on this suppressor strain.
A mutation inmlaA is implicated in suppression of PS102 bacitracin sensitivity.
Strain PS102 harbors, in addition to mutations in lacZ and in intergenic regions, a
nucleotide insertion that causes a frameshift mutation at codon 193 of tus (here named
the tus-102 mutation) and a 6-nucleotide deletion in mlaA (here named the mlaA102
allele) that removes amino acids N41 and F42 of the encoded MlaA protein (Table 1).
Tus is a nonessential E. coli protein implicated in replication termination at ter sites
(43). MlaA is the OM lipoprotein component of the Mla system, which is thought to
maintain OM lipid asymmetry in E. coli (10). Therefore, we sought to determine whether
mlaA102 and/or tus-102 mutations could be implicated in the suppression of bacitracin
sensitivity observed in strain PS102. We therefore sequenced the chromosomal mlaA
and tus genes from ﬁve independent members of this class of suppressor mutants and
found that three of them harbored the same mlaA102 allele; in another mutant, an IS1
element was inserted downstream of mlaA codon 227, whereas in the last one, no
mutation was present in mlaA. The tus genes of these ﬁve independent mlaA mutants
were sequenced and did not bear any mutation, indicating that tus-102 is not impli-
cated in suppression.
To genetically characterize mlaA102, we transformed wild-type, lptA41, and ΔmlaA
strains with plasmids expressing the wild-type and the mutant mlaA alleles from the
ptac promoter and assessed the impacts of the different mlaA and lptA alleles, in all
possible combinations, on OM permeability using bacitracin and SDS-EDTA as probes.
Bacitracin was used at a concentration (50 g/ml) that reliably discriminates lptA41
from the suppressors, independently of the concentrations used from the selection and
the genetic background. We used SDS-EDTA at concentrations of 0.5% and 0.25 mM,
respectively, which are tolerated by wild-type strains. The complementation and sup-
pression tests are summarized in Table 2. Both wild-type and ΔmlaA strains (Table 2,
TABLE 2 Phenotypic suppression pattern of the mlaA102 allele
Strain
Chromosomal
version of: Plasmid EOPa
RowlptA mlaA lptAb mlaAc LD
Bct
(50 g/ml) SDS EDTA
PS001 ΔlptA mlaA lptA NP    1
    2
mlaA    3
mlaA102    4
PS003 ΔlptA mlaA lptA41 NP    5
    6
mlaA    7
mlaA102    8
PS102 ΔlptA mlaA102 lptA41 NP    9
    10
mlaA    11
mlaA102    12
PS130 ΔlptA ΔmlaA lptA NP    13
    14
mlaA    15
mlaA102    16
PS107 ΔlptA ΔmlaA lptA41 NP    17
    18
mlaA    19
mlaA102    20
aEOP relative to growth on LD agar. , EOP  102; , EOP  103.
blpt, pWSK29-LptA LptB; lptA41, pWSK29-LptA41 LptB.
cNP, no plasmid; , empty vector pGS100; mlaA, pGS100-MlaA; mlaA102, pGS100-MlaA102.
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compare rows 1 to 3 with 13 to 15) appear to tolerate SDS-EDTA. In a previous report,
an E. coli ΔmlaA mutant was shown to be sensitive to a critical SDS-EDTA concentra-
tions (Sdss) but not to other drugs, including bacitracin (10). Under our experimental
conditions, however, both wild-type and ΔmlaA strains did not tolerate higher SDS-
EDTA concentrations. The lptA41 strain PS003 showed severe permeability defects, as in
addition to bacitracin, it showed increased sensitivity to SDS-EDTA compared to the
isogenic wild-type strain (compare rows 1 and 2 with 5 and 6). Ectopic expression of
mlaA102 was sufﬁcient to restore resistance to bacitracin in lptA41 mutant strains, both
in the haploid (row 20) and in the heterozygous (row 8) states. Interestingly, under both
conditions, mlaA102 also conferred sensitivity to SDS, suggesting that mlaA102 is (at
least partially) a dominant-negative mutant that suppresses the bacitracin sensitivity of
lptA41. As mlaA102 also confers the Sdss phenotype irrespective of the presence of the
wild-type mlaA allele (rows 4 and 11), it can be hypothesized that mlaA102 is a
gain-of-function allele that negatively affects OM permeability. This is in line with the
ﬁnding that in the PS102 suppressor strain, the lipid A modiﬁcation pattern is very
similar to that observed in the parental PS003 mutant (Fig. 3), further strengthening the
hypothesis that the suppression mechanism does not act through restoration of the
OM permeability barrier.
Bacitracin resistance in an mlaA102 suppressor mutant is associated with
hypervesiculation. The PS102 mutant could suppress bacitracin sensitivity while not
restoring the OM permeability barrier. To gain hints about the mechanism of suppres-
sion of bacitracin sensitivity bymlaA102, we analyzed the composition of the OM in the
suppressor mutant and in the corresponding isogenic parental strains. The analysis of
LPS levels from whole-cell lysates of the PS102 mutant compared with the isogenic
lptA (PS001) and parental lptA41 (PS003) strains failed to reveal any difference
(Fig. 2C). We then analyzed PS102 IM and OM protein proﬁles. Whole-cell lysates
obtained from PS003 and PS102 were fractionated by sedimentation on sucrose density
gradients, as described in Materials and Methods. The fractions were assayed by
SDS-PAGE, followed by Coomassie staining for OmpC, OmpF, and OmpA porin proﬁles
and by immunoblotting with antibodies against LamB (these antibodies cross-react
with OmpA [16]), LptD, LptB, and LPS. The fractionation proﬁle of the isogenic PS001
wild-type strain was used as a reference in this experiment.
As shown in Fig. 5A, in PS001 cells, the OM equilibrated at fractions 20 to 24, as
deﬁned by the distribution proﬁle of LPS, porins, and LptD. Conversely, the IM equili-
brated at fractions 4 to 6, as judged by the proﬁle of the IM-associated protein LptB. In
PS003 mutant cells, the IM and OM equilibrated at the same densities as in the
wild-type strain PS001, as witnessed by LptB and porin distributions, respectively. A
slightly greater accumulation of LPS in the IM than in the OM fractions was observed
in PS003, in agreement with the LPS transport impairment associated with the lptA41
allele (Fig. 5B). Interestingly, in suppressor PS102 cells, the distribution of porins, LPS,
and LptD was skewed toward fractions 16 to 20, with densities lower than those of
strain PS003 (fractions 20 to 24), indicating that in this mutant, the OM ﬂoated at a
density lower than that of the parental strain, PS003. Of note, LPS distribution between
the IM and the OM was comparable to that in PS003 (Fig. 5C), conﬁrming that LPS
transport was not restored in the PS102 mutant. We suggest that the lower OM density
in PS102 might result from a lower LPS/PL ratio than in the PS003 OM, associated with
mlaA102 mutation.
The same mlaA102 allele (referred to as mlaA*) was recently associated with a novel
cell death mechanism that occurs under starvation conditions in medium with limited
cation concentrations (44). Notably, in cells carrying the mlaA* mutation, PL accumu-
lation at the OM leads to increased OM blebbing at cell division sites (44). As PS102
showed an altered OM (Fig. 3E and 5C), we assessed whether increased outer mem-
brane vesicle (OMV) production was an additional phenotype of the PS102 mutant. To
test this hypothesis, we ﬁltered culture supernatants of the PS102 mutant and its
parental strain, PS003, to eliminate whole cells and concentrated samples by ultraﬁl-
tration to collect OMVs. The ultraﬁltered samples were analyzed by SDS-PAGE and
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immunoblotting using antibodies directed against OM (LamB and LptE) and periplas-
mic (maltose binding protein [MBP]) proteins, whose levels are indicative of OM
vesiculation. As a control, we analyzed the isogenic wild-type strain PS001. As shown in
Fig. 6A, we detected the periplasmic MBP in ﬁltered supernatants of PS001, PS003, and
PS102. The substantial increase in OM markers only in the supernatant of PS102
suggested that the mutant hypervesiculates compared to the isogenic wild type and its
parental strain, PS003. This ﬁnding was also conﬁrmed by the presence of OM blebbing
in microphotographs of PS102 mutant cells (Fig. 7). Interestingly, the IM-associated
LptB protein was also detected in OMVs from PS102, probably reﬂecting the ability of
the protein to colocalize with the OM (14). The presence of MBP alone in PS003
supernatant appeared to be related to leakage of proteins into the growth medium, as
assessed by SDS-PAGE and Coomassie blue staining of the corresponding culture
supernatants that showed a protein proﬁle identical to that of total cell lysates (Fig. 6B).
Leakage of proteins in culture media is a common phenomenon in envelope biogenesis
mutants (45).
An additional amino acid substitution in LptA41 and a missense mutation in
opgH contribute to lptA41 suppression in PS103. In the suppressor strain PS103,
resistance to bacitracin, rifampin, and SDS-EDTA and partial resistance to novobiocin
were restored. The altered OM permeability proﬁle of PS103 is in line with the ﬁnding
that only hexa-acylated lipid A decorated with PEtN and not the hepta-acylated lipid A
species could be detected in the mutant (Fig. 3F). Genomic sequencing of PS103
revealed that, besides the additional mutation in the plasmid-borne lptA41 allele that
generated the lptA42 allele, the strain harbored a W415Stop mutation in opgH (opgH103
allele) (Table 1). opgH (formerly mdoH) encodes an IM glycosyltransferase of 847 amino
acids implicated in both the synthesis of osmoregulated periplasmic glucans (OPGs),
also known as membrane-derived oligosaccharides (MDOs) (46, 47), and the control of
cell size via interaction with FtsZ in a nutrient-dependent manner (48). We thus
FIG 5 Membrane fractionation of wild-type, lptA41, and suppressor strains. Cultures of PS001 (lptA) (A),
PS003 (lptA41) (B), PS102 (mlaA102) (C), and PS103 (lptA42 opgH103) (D) strains were grown to an OD600
of 0.6. Crude extracts were fractionated on a sucrose density gradient. Fractions were collected from
the top of the gradient. The proﬁles of the major OM porins (OmpC/F-OmpA) were determined by
SDS-PAGE, followed by Coomassie blue staining. LamB-OmpA and LptD proﬁles were determined as OM
markers by immunoblotting using anti-LamB and anti-LptD antibodies, respectively. LptB was detected
as an IM marker using anti-LptB antibody. LPS distribution across fractions was determined by Tricine
SDS-PAGE and immunoblotting using anti-LPS WN1 222-5 monoclonal antibody. The numbers are
fraction numbers.
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analyzed the possible contribution of each mutation to the suppressed phenotype
exhibited by strain PS103.
As expected, the LptA42 mutant protein retained the ability to copurify LPS in vitro
(Fig. 4B). We then tested Lpt complex assembly by performing afﬁnity puriﬁcation
experiments from solubilized membranes of a strain bearing the lptA42 allele and
ectopically expressing LptC-H. As shown in Fig. 2C, the steady-state level of LptA42
appeared to be higher than that of LptA41, suggesting that the LptAM112I mutation
slightly improved protein stability. Afﬁnity puriﬁcation from solubilized membranes of
PS103 using LptC-H as bait revealed partially restored LptA42-LptC interaction, as
judged by the increased amount of an LptA42 degradation product in Western blot
FIG 6 OMV isolation and determination of protein release in cell supernatants. (A) Whole-cell lysates
(WCL) and OMVs from PS001 (lptA), PS003 (lptA41), and suppressor strains PS102 (mlaA102) and PS103
(lptA42 opgH103) were prepared, separated by SDS-PAGE, and analyzed by immunoblotting using
anti-LamB, anti-LptE, anti-MBP, and anti-LptB antibodies. (B) Pellets containing equal numbers of cells,
based on the OD600, and 20-fold-concentrated culture supernatants of strains PS001, PS003, PS102, and
PS103 were subjected to SDS-PAGE and stained with Coomassie blue. Molecular mass markers are
indicated.
FIG 7 Morphology of lptA41 and suppressor cells. Shown are phase-contrast and membrane stain
(FM5-95) images of PS001 (lptA), PS003 (lptA41), suppressor strains PS102 (mlaA102) and PS103 (lptA42
opgH103), PS132/pOpgH103 (ΔopgH ectopically expressing OpgH103 mutant protein), and PS111
(lptA42). Cell length measurements are reported in Table 5. The arrows in suppressor strain PS102
indicate OMVs.
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analysis using anti-LptA antibodies and by the enrichment of LptD (Fig. 4A). These data
suggest that in the PS103 mutant, the Lpt complex could assemble, albeit with weaker
afﬁnity than in the wild type (Fig. 4A).
In line with the above-mentioned data is the ﬁnding that both the analysis of LPS
levels from whole cells and the membrane fractionation proﬁle of PS103 failed to show
relevant differences in membrane composition relative to the parental strain, PS003
(Fig. 2C and 5D). We thus analyzed the contributions of the opgH103 and lptA42 alleles,
alone or in combination, to the suppression of sensitivity to toxic compounds in a
suitable set of strains harboring ectopic and chromosomal lptA and opgH alleles in
different combinations. It should be mentioned that E. coli ΔopgH strains have been
reported to be sensitive to 0.5% SDS (49). However, under our experimental condi-
tions, the ΔopgH mutant was tolerant of 0.5% SDS and 0.25 mM EDTA, whereas, as
shown in Table 2, the lptA41 mutant was sensitive.
The data presented in Table 3 indicate that (i) in the PS103 suppressor strain (row
1), tolerance for bacitracin, SDS, and rifampin has been restored, whereas sensitivity to
novobiocin was only partially suppressed compared with the parental strain (line 6),
and (ii) the lptA42 allele was sufﬁcient to restore bacitracin and SDS tolerance but not
rifampin or novobiocin tolerance in a wild-type chromosomal opgH background (lines
10 and 11). On the other hand, lptA42 fully restored rifampin tolerance and partially
restored novobiocin tolerance only in the absence of a wild-type opgH allele, irrespec-
tive of its chromosomal or plasmid location (compare lines 22, 23, and 25 with 10 to 12
and 24). The merodiploid opgH opgH103 heterozygous strain (ectopic opgH103) was
only partially tolerant of novobiocin (line 13), indicating that the opgH103 allele is
recessive to the wild-type opgH allele.
The opgH103 allele reduces mutant cell size. In E. coli, inactivation of opgH leads
to increased expression of colanic acid (CA) (50). Consistently, our ΔopgH and opgH103
strains produced mucoid colonies. To test whether colanic acid production could play
TABLE 3 Phenotypic suppression pattern for lptA42 and opgH103 alleles
Strain
Chromosomal
version of: Plasmid EOPa
RowlptA opgH lptAb opgHc LD Bct (150 g/ml) SDS-EDTA Rif (2.5 g/ml) Nov (10 g/ml)
PS103 ΔlptA opgH103 lptA42 NP      1
PS001 ΔlptA opgH lptA NP      2
      3
opgH      4
opgH103      5
PS003 ΔlptA opgH lptA41 NP      6
      7
opgH      8
opgH103      9
PS111 ΔlptA opgH lptA42 NP      10
      11
opgH      12
opgH103      13
PS112 ΔlptA ΔopgH lptA NP      14
      15
opgH      16
opgH103      17
PS109 ΔlptA ΔopgH lptA41 NP      18
      19
opgH      20
opgH103      21
PS110 ΔlptA ΔopgH lptA42 NP      22
      23
opgH      24
opgH103      25
aEOP relative to growth on LD agar. , EOP  102; , EOP between 102 and 103; , EOP  103.
blptA, pWSK29-LptA LptB; lptA41, pWSK29-LptA41 LptB; lptA42, pWSK29-LptA42 LptB.
cNP, no plasmid; , empty vector pGS100; opgH, pGS100-OpgH; opgH103, pGS100-OpgH103.
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any role in the suppressed phenotype, we inactivated the wcaJ gene, which codes for
the UDP-glucose lipid carrier required for the biosynthesis of CA (51, 52). Deletion of
wcaJ in PS103 and in the PS132 ΔopgH lptA42 mutant strain barely affected the
antibiotic resistance of the parental strains (Table 4), suggesting that CA overproduc-
tion in PS103 is not implicated in suppression of the increased antibiotic susceptibility.
Interestingly, inactivation of wcaJ in the ΔopgH mutant expressing the lptA41 allele
conferred some amelioration of OM permeability. Overall, these results suggest that
suppression of the lptA41 phenotype in PS103 is ensured by the combination of LptA
mutation and the production of a truncated OpgH protein and is independent of CA
production.
OpgH has been implicated in modulating cell size by antagonizing the assembly of
FtsZ at the nascent septal site (48). We therefore determined whether the production
of a truncated OpgH protein impacted cell size by comparing the average size of PS103
mutant cells with those of the parental PS003, the isogenic wild-type PS001, and the
suppressor PS102 cells. As shown in Fig. 7 and Table 5, PS103 mutant cells were 28.8%
and 19.1% smaller than those of strains PS003 and PS001, respectively. On the other
hand, suppressor PS102 mutant cells were similar in size to the parental PS003 cells,
suggesting that the slight decrease in cell size may have a role in the PS103-speciﬁc
mechanism of lptA41 phenotype suppression.
DISCUSSION
LptA is the periplasmic component of the Lpt machine that ferries LPS across the
periplasm to the cell surface. LptA connects, supposedly as a head-to-tail dimer/
oligomer (27, 34), the inner membrane ABC transporter formed by the LptB2FGC
subcomplex with the OM LptDE translocon by contacting the C-terminal region of LptC
at the IM and the N-terminal region of LptD at the OM via its N- and C-terminal
domains, respectively (19, 20, 32). LptA also binds LPS and is thought to provide a
hydrophobic environment for the passage of the amphipathic LPS through the
periplasm (21, 40). LptA is the prototype of the peculiar -jellyroll fold (27), conserved
in LptC (29), the N-terminal domain of LptD (25, 31), and the periplasmic domains of
LptF and LptG (30) and thought to be relevant for both protein-protein and protein-LPS
TABLE 4 Colanic acid production does not affect PS103 suppressor phenotype
Strainb
Chromosomal
version of:
Plasmid
lptAc
EOPa
RowopgH wcaJ LD Bct (50 g/ml) Bct (150 g/ml) Rif (2.5 g/ml) Nov (10 g/ml)
PS103 opgH103 wcaJ lptA42      1
PS113 opgH103 ΔwcaJ lptA42      2
PS112 ΔopgH wcaJ lptA      3
PS109 ΔopgH wcaJ lptA41      4
PS110 ΔopgH wcaJ lptA42      5
PS116 ΔopgH ΔwcaJ lptA      6
PS114 ΔopgH ΔwcaJ lptA41      7
PS115 ΔopgH ΔwcaJ lptA42      8
aEOP relative to growth on LD agar. , EOP  102; , EOP between 102 and 103; , EOP  103.
bAll the strains harbor the ΔlptAB::kan chromosomal deletion.
clptA42, pWSK29-LptA42 LptB; lptA, pWSK29-LptA LptB; lptA41, pWSK29-LptA41 LptB.
TABLE 5 Cell lengths
Strain Relevant genotype Lengtha (m  SD)
PS001 ΔlptAB/pWSK29lptAB 3.40 0.52
PS003 ΔlptAB/pWSK29lptA41lptB 3.86 0.63
PS102 ΔlptAB vacJ102/pWSK29lptA41lptB 3.90 0.67
PS103 ΔlptAB opgH103/pWSK29lptA42lptB 2.75 0.57
PS132/pOpgH103 ΔopgH/pGS100-opgH103 2.52 0.51
PS111 ΔlptAB/pWSK29lptA42lptB 3.10 0.67
aAverage lengths of cells from 100 cells per strain.
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interactions. In agreement with structural data, photo-cross-linking studies have iden-
tiﬁed speciﬁc residues implicated in LptA-LptC and LptA-LPS interactions (21, 32).
Despite the wealth of information available to date, several aspects of the molecular
basis of LptA function remain elusive, highlighting the need for structure-function
studies. LptA is essential for cell viability (17), and the only nonviable mutants in lptA
isolated so far have been Q111P (36) and G138R (28) substitutions; however, it is not
known how the above-mentioned mutations affect LptA function.
In order to gain further information about the molecular role of LptA in LPS
transport, we generated a mutant LptA protein potentially impaired in interactions with
LPS and/or other Lpt proteins by changing four residues (I36, I38, R76, and K83) that lie
at the N-terminal rim of the LptA internal cavity and are conserved in representative
gammaproteobacteria (27). Furthermore, I36 and I38 are located in a region implicated
by photo-cross-linking in LptA-LptC and/or LptA-LptA interaction (32). Such a quadru-
ple mutant (lptA41) complemented both LptA-depleted cells and lptA deletion mutants
for viability; thus, modiﬁcation of the above-mentioned four residues is not sufﬁcient to
abolish LPS transport to the OM. LptA41 did not seem to be compromised in LPS
binding, whereas it failed to interact with LptC in afﬁnity puriﬁcation experiments using
His-tagged LptC as bait. This suggests that LptA41-LptC interaction is too weak to be
detected by afﬁnity puriﬁcation but is sufﬁcient to form a functional, albeit partially
impaired, Lpt complex. It has been previously reported that in vitro LptA-LptC interac-
tion and LptA self-oligomerization are independent of LptA or LptC binding to LPS, as
these interactions can occur in the absence of LPS, as assessed by size exclusion
chromatography and electron paramagnetic resonance (EPR) and nuclear magnetic
resonance (NMR) spectroscopy (53–55). However, it is not possible to exclude the
possibility that, in vivo, LPS binding inﬂuences LptA assembly within the Lpt complex.
To our knowledge, this is the ﬁrst lptA mutant in which LPS binding to LptA and
LptA-LptC interaction can be genetically separated. Notably, mutant Lpt machines
missing the LptC component but carrying speciﬁc amino acid substitutions of a single
residue in the LptF periplasmic domain have been identiﬁed (56). This ﬁnding suggests
that under speciﬁc conditions, LptA-LPS binding is independent of LptA-LptC interac-
tion. Clearly, in the mutant Lpt machines missing the LptC component, different
protein-protein and protein-LPS interactions must occur to ensure functional LPS
transport.
Although E. coli lptA41 is viable, the mutant exhibits increased sensitivity to three
antibiotics (the large hydrophilic bacitracin and the hydrophobic rifampin and novo-
biocin [6]) and to the detergent SDS. Such a sensitivity proﬁle is diagnostic of a
defective OM that is more accessible to the detergent, which may disrupt the OM itself,
and more permeable to antibiotics, which must diffuse through the OM to reach their
targets either in the periplasm (bacitracin) or in the cytoplasm (rifampin and novobio-
cin). Multiple mechanisms may contribute to the increased permeability of the OM (4,
57). Among these, defective LPS transport may interfere with OM protein assembly and
increase the PL concentration in the outer leaﬂet of the OM, thus making the mem-
brane more permeable to lipophilic molecules, such as rifampin and novobiocin. On the
other hand, bacitracin, a hydrophilic molecule too large to diffuse through porins, may
enter the periplasm through transient breaching (“cracks”) in the OM bilayer at disor-
dered LPS-PL junctions (58). In the lptA41 mutant, LPS transport may not be as efﬁcient
as in the wild type, thus leading to a defective OM with increased LPS-PL junctions.
Accordingly, in this mutant, we observed LPS species with hepta-acylated (both mono-
and diphosphorylated) lipid A or decorated by PEtN. The former modiﬁcation, catalyzed
by the lipid A palmitoyltransferase PagP, is induced by translocation of PLs to the outer
leaﬂet of the OM (8, 59), where PLs are used as palmitoyl donors, and is consistent with
the hypothesis of defective transport. On the other hand, PEtN decoration, promoted
by EptA (3, 38) and known to be induced by exposure of cells to mild acid (60) or
antimicrobial peptides (61), occurs on the outer surface of the IM (38), where LPS might
idle under conditions of inefﬁcient transport (15, 24). Although such lipid A modiﬁca-
tions may be part of the homeostatic cell response to diverse envelope stress condi-
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tions, they do not appear to be sufﬁcient to fully restore the OM permeability barrier
in the lptA41 mutant.
By searching for spontaneous phenotypic revertants to bacitracin resistance (Bctr),
we obtained suppressors showing different antibiotic resistance proﬁles, none of which
fully reverted to the resistant phenotype of the lptA wild-type parental strain.
The suppressor mutation of strain PS102 is mlaA102, a two-codon, in-frame deletion
in mlaA. In E. coli, MlaA is the OM lipoprotein component of the Mla machinery, which
is thought to contribute, together with other systems, to the maintenance of OM lipid
asymmetry by removing PLs from its outer leaﬂet (10). It has been suggested that upon
disruption of the Mla system, PL rafts accumulate in the OM outer leaﬂet (10, 62).
Notably, the same mlaA in-frame deletion (named mlaA*) has been recently isolated as
responsible for suppressing the bacitracin sensitivity of an lptD mutant defective in LPS
assembly at the OM (44). Moreover, the IM MlaD protein increases in abundance in cells
where LPS transport is severely impaired (63). These ﬁndings further strengthen a
functional link between the Mla system and the Lpt machinery.
Disruption of the Mla system does not signiﬁcantly impair the OM permeability
barrier but facilitates access to detergents, as shown by increased sensitivity to a
critical SDS (0.5%)-EDTA (1.1 mM) concentration (10). However, under our experi-
mental conditions, the mlaA deletion mutants analyzed in this work tolerate SDS
(0.5%)-EDTA (0.25 mM) like their isogenic parental strains (Table 2), whereas neither
could grow in the presence of higher SDS-EDTA concentrations. This discrepancy
with previously reported data might be ascribed to the genetic differences in
laboratory strains and/or laboratory conditions. Interestingly, the mlaA102 allele
confers increased sensitivity to SDS but not to bacitracin under both haploid and
merodiploid heterozygous conditions, suggesting that mlaA102 is a dominant-
negative mutation that impairs the Mla system. These observations ﬁt the role
proposed for mlaA* as a gain-of-function allele that transfers PLs from the inner to
the outer leaﬂet of the OM, which is the reverse of mlaA wild-type activity (44). The
mlaA* allele has been shown to be associated with cell death in stationary phase
occurring after loss of OM material through vesiculation because of an increased
LPS level and fatty acid depletion (44). The phenotypes associated with PS102,
namely, persistence of lipid A modiﬁcations (Fig. 3E), decreased OM density, and
altered LPS distribution between the IM and OM (Fig. 5C), indicate that in this
suppressor, LPS transport is still impaired and the integrity of the OM is compro-
mised, possibly as a consequence of PL translocation to the outer leaﬂet of the OM.
However, unlike the mlaA* mutant, PS102 showed no increase in LPS level com-
pared with its parental wild-type strain (Fig. 2C) and does not appear to undergo
cell death, in agreement with the ﬁnding that a decreased LPS level in the OM due
to LPS transport impairment suppresses the death phenotype of mlaA* cells (44).
The mlaA102 allele suppresses sensitivity to bacitracin caused by lptA41, whereas
it does not restore tolerance for rifampin and novobiocin, suggesting that the
suppressor mutation is speciﬁc for bacitracin resistance. While the presence of PL
rafts justiﬁes the sensitivity of PS102 to the hydrophobic rifampin and novobiocin,
it is not immediately evident how the suppressor mutant recovers resistance to the
large hydrophilic polypeptide antibiotic bacitracin. It has been shown that accu-
mulation of PLs in the outer leaﬂet of the OM leads to OMV formation (61).
Accordingly, the mlaA102 mutant has been shown to hypervesiculate. In addition to
playing important roles in Gram-negative bacterial physiology and pathogenesis,
OMV production has been shown to be a strategy to increase resistance to
antibacterial molecules by sequestering them from the cellular targets, as in the
cases of colistin and polymyxin B (64). We thus propose that in the PS102 suppres-
sor strain hypervesiculation speciﬁcally restores Bctr. Bacitracin is a cyclic polypep-
tide that interferes with generation of undecaprenyl phosphate (C55-P) from its
precursor, undecaprenyl pyrophosphate (C55-PP) (65), for the synthesis of cell wall
polysaccharides, such as peptidoglycan, LPS O antigen, and teichoic acids (3, 66,
67). In E. coli, Bctr has been shown to occur through several indirect mechanisms,
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including ampliﬁcation of the C55-PP phosphatase BacA or mutations impairing the
production of colanic acid that otherwise would contribute to further deplete the
pool of C55-PP carrier (68), and unlike rifampin and novobiocin, no chromosomal
mutations in the antibiotic target can be isolated (69). In this work, we highlight a
novel potential mechanism of Bctr involving removal of the antibiotic from its target
via hypervesiculation. Interestingly, recent selection for E. coli mutants resistant to
a novel expanded-spectrum antibiotic (tigecycline) has allowed the isolation of the
same mlaA two-codon deletion present in the mlaA102 allele (70); whether this may
involve a hypervesiculation mechanism as well needs to be proved.
In the suppressor strain PS103, bacitracin, rifampin, and SDS tolerances were re-
stored, whereas novobiocin sensitivity was not fully suppressed. The additive effects of
an intragenic suppressor and an extragenic suppressor appear to contribute to this
phenotype.
The intragenic suppressor (lptA42 allele) encodes an additional amino acid change
(M112I) in LptA41. The LptA42 quintuple-mutant protein partially recovered the ability
to copurify with LptC, and it appeared to be more stable than LptA41, as judged by the
higher steady-state level of the protein. We suggest that this phenotype is due to the
reintroduction of an isoleucine residue pointing toward the interior of the cavity of
LptA (Fig. 2A). Interestingly, the region around the M112 residue of LptA has been
recently reported to undergo a chemical shift perturbation in the presence of LptC and
LPS in NMR experiments (55).
The lptA42 allele was sufﬁcient to restore tolerance for bacitracin and SDS but not
for rifampin and novobiocin in a wild-type chromosomal opgH background. The
partially restored OM asymmetry would prevent the formation of PL rafts, which may
favor access to detergents and decrease the number of LPS-PL junctions in the OM and
hence permeability to large hydrophilic molecules, such as bacitracin. In keeping with
this hypothesis, in the PS103 strain, hepta-acylation of lipid A was not observed
(Fig. 3F). Nevertheless, since LPS transport was not restored to wild-type levels, as
witnessed by persistence of lipid A decorated by PEtN and LPS distribution between the
IM and the OM, the LPS layer would remain sufﬁciently weakened to allow diffusion of
hydrophobic compounds.
The extragenic suppressor associated with PS103 is an amber mutation within the
opgH reading frame, which encodes a Glucosyltransferase implicated in the biosynthe-
sis of the so-called OPGs, a class of D-glucose oligosaccharides, heterogeneous in size
and structure, found in the periplasm of all proteobacteria (47). OPGs, whose synthesis
is induced by low osmolarity (46, 71), have been implicated in several processes,
including chemotaxis, virulence, osmoregulation of OM protein expression, synthesis of
CA, and resistance to SDS (49, 50, 72, 73), but the underlying mechanisms are poorly
understood. Here, we showed that the opgH103 allele does not exert its effect by
inducing CA production, even if inhibition of CA production in the ΔopgH strain
carrying the lptA41 allele ameliorated OM permeability (Table 4, compare row 4 with
row 7).
In addition to its enzymatic role in OPG biosynthesis, OpgH has been implicated in
control of cell division as a UDP-glucose-activated inhibitor of FtsZ ring formation in E.
coli (48). OpgH is an integral membrane protein that contains 8 transmembrane
domains, with the N and C termini located in the cytoplasm (74). OpgH has three
cytoplasmic domains encompassing residues 1 to 138 (termed the N domain), 211 to
514 (termed the M domain), and 702 to 848 (termed the C domain) (48). The model of
OpgH functioning postulates that UDP-glucose binding to the M domain leads to a
conformational change that promotes cell division inhibition mediated by the N
domain (48). The opgH103 allele produces a truncated OpgH comprising the N domain
and part of the M domain. Deletion of both opgH and the opgH103 nonsense mutation
restores resistance to rifampin and, partially, to novobiocin in the lptA42 mutant, thus
recapitulating the phenotype of the PS103 suppressor strain. opgH103 also appears to
be recessive (strain PS111 with ectopic opgH103 is Rifs, albeit not fully Novs). It thus
seems that the lack of OPGs in the periplasm and/or of the full-length OpgH in the IM
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makes the cell envelope of E. coli lptA42 less permeable to the lipophilic antibiotic
rifampin and, to a lesser extent, to novobiocin, which is about 3-fold more lipophilic
than rifampin (6). PS103 cells are smaller than the parental PS003 cells, and this
phenotype seems to be correlated with the opgH103 allele, since the PS132 ΔopgH
strain with ectopic opgH103 shared the same phenotype. Therefore, decreased cell size,
and hence membrane surface, might help the cell to cope with impaired LPS transport
of the lptA42 allele. Similarly, decreased cell size and growth rate due to alteration of
fatty acid biosynthesis have been previously shown to suppress mutations that confer
LPS transport defects (75).
In conclusion, in this work, we have identiﬁed two different mechanisms that ﬁx, at
least partially, the OM permeability barrier compromised in a mutant with defective LPS
transport to the cell surface. In the case of the mlaA102 mutant, the suppression
appears to be quite speciﬁc for the antibiotic used for the selection and relies on the
peculiar function acquired by themlaA102 gain-of-function allele that is associated with
hypervesiculation. In the case of the PS103 suppressor, on the other hand, we found a
more global mechanism based on the synergistic effect of LptA mutation/stabilization
and modulation of the cell size associated with the opgH103 allele.
Overall, this work revealed different strategies adopted by the cell to preserve OM
barrier integrity. An understanding of the molecular mechanisms underlying the per-
meability properties of the OM is fundamental for the design of novel antibacterial
drugs and for the improvement of our current arsenal of antibiotics.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The E. coli strains and plasmids used in this
study are listed in Tables 6 and 7, respectively, with a brief outline of their construction by standard
techniques. The oligonucleotides used in strain and plasmid construction are listed in Table 8. All the
cloned DNA regions obtained by PCR were sequenced to rule out the presence of mutations. Site-
directed Red-mediated mutagenesis of E. coli was performed as described previously (76) and as
speciﬁed in Table 6. ΔlptAB::kan DNA was obtained by three-step PCR using the external primers
AP54-AP267 and, as templates, the kan cassette PCR ampliﬁed from pKD4 using AP79-AP80 primers and
the two ﬂanking homology regions obtained by PCR ampliﬁcation of E. coli MG1655 DNA with
oligonucleotide pairs AP54-AP268 and AP266-AP267. Transduction with P1 HFT (77) was performed as
described previously (78). Unless otherwise stated, bacteria were grown at 30°C in LD (79) or M9 minimal
medium supplemented with 0.2% glucose as a carbon source (80) and, when required, 0.1 mM IPTG
(isopropyl--D-thiogalactopyranoside), 100 g/ml ampicillin, 30 g/ml chloramphenicol, and 25 g/ml
kanamycin. Solid media were as described above with 1% (wt/vol) agar.
Isolation of bacitracin-tolerant phenotypic revertants. Independent overnight cultures of PS003
were grown from single colonies in 10 ml of LD medium supplemented with ampicillin, pelleted, and
individually resuspended in 100 l of LD before plating onto LD agar with bacitracin at the indicated
concentrations. Upon overnight incubation at 37°C, Bctr phenotypic revertants were colony puriﬁed in
the presence of bacitracin.
Outer membrane permeability assay. OM sensitivity was evaluated by measuring the efﬁciency of
plating (EOP) on LD agar plates containing bacitracin, rifampin, novobiocin, and SDS-EDTA at noninhibi-
tory concentrations for the reference (wild-type) strain, as indicated. Overnight cultures were grown from
single colonies in 5 ml LD supplemented with the antibiotic required for the maintenance of the hosted
plasmid. Cultures were serially diluted in LD in microtiter plates, replica plated on the selective LD agar
plates, and incubated overnight (or up to 24 h). The EOP was estimated relative to plating on LD agar.
Genomic-DNA sequencing and data analysis. The library for genomic-DNA sequencing was
prepared according to the TruSeq DNA sample preparation protocol (Illumina). Brieﬂy, 1 g of genomic
DNA was sonicated into fragments with a median length of 400 bp; after end repair, indexed adapters
were ligated at the DNA fragment ends, and the libraries were quantiﬁed by quantitative real-time PCR
(qPCR) using Kapa Library Quant kits (Kapa Biosystems). After a short ampliﬁcation step, the library was
sequenced on an Illumina GAIIX sequence analyzer to generate 85-bp paired-end reads. The raw reads
were individually mapped to the E. coliMC4100 genome (RefSeq accession number HG738867) using the
accurate alignment BWA mem algorithm (81) allowing 1% error. Removal of duplicated reads was
performed with SAMtools (82); only high-quality reads having mapping quality score (MAQ) values of
30 were used for the analysis of variant detection. A VCF ﬁle containing all the variants for each sample
relative to E. coli MC4100 was obtained by using SAMtools and Bcftools (82) and ﬁltered for low-quality
variants. SNVs having coverage lower than ﬁve high-quality reads were discarded. Predicted indel
mutations having coverage lower than six high-quality reads were discarded. Then, the VCF ﬁles were
analyzed using SNPeff version 4.0 (83), and high-quality SNVs and indels were subsequently annotated
to determine their effects and impacts on coding sequences.
Determination of LptA abundance. LptA abundance was assessed by Western blot analysis.
Bacterial cultures were grown overnight at 30°C in LD supplemented with 100 g/ml of ampicillin.
Samples for protein analysis were centrifuged for 5 min at 16,000  g, and the pellets were resuspended
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in a volume (in milliliters) of SDS sample buffer equal to 1/24 of the total optical density (OD) of the
sample. The samples were boiled for 10 min, and equal volumes (20 l) were fractionated by SDS-12.5%
polyacrylamide gel electrophoresis. Proteins were transferred onto nitrocellulose membranes (GE Health-
care), and Western blot analysis was performed as previously described (17). Polyclonal sera raised
against LptA (GenScript Corporation) were used as primary antibodies at a dilution of 1:1,000. Goat
anti-mouse immunoglobulins (Li-Cor) were used as secondary antibodies at a dilution of 1:7,000, and
bands were visualized by an Odyssey Fc imaging system (Li-Cor GmbH). The band analysis tools of Image
Studio Lite software version 5.0 (Li-Cor GmbH) were used to perform densitometric analysis of band
intensity.
Lipid A analysis by mass spectrometry. E. coli strains were grown in 1 liter of LD supplemented
with 100 g/ml of ampicillin up to an OD at 600 nm (OD600) of 0.9, yielding approximately 1 g of
lyophilized biomass, at 30°C under different conditions, as speciﬁed. Cells were harvested by centrifu-
gation at 4°C (5,000  g; 15 min). The cell pellets were washed once with 20 ml of phosphate-buffered
saline (PBS), 0.1 mM, pH 7.4, and lyophilized. Each pellet was treated twice with 10 ml of PCP solution
(petroleum ether-chloroform-phenol, 90%; 2:5:8 [vol/vol/vol]) (84). For each strain, the two supernatants
were removed at each passage by centrifugation (5,000 rpm; 10 min), pooled, and concentrated in a
rotary evaporator to a ﬁnal volume of approximately 3 ml. Lipooligosaccharide (LOS) precipitation
occurred by dropwise addition of water (ca. 0.35 ml). The solid phase was recovered by centrifugation,
dissolved in water, dialyzed (cutoff, 12,000 to 14,000 Da) against water for 2 days with ﬁve water changes,
and freeze-dried. On average, 5 mg of pure LOS was obtained for each strain. LOS (0.5 to 1.5 mg) was
dissolved in 0.5 ml of 1% acetic acid (AcOH) in water and heated at 100°C for 2 h to cleave the lipid A
moiety that was recovered as a precipitate after centrifugation (5,000 rpm; 30 min) in 20 to 25% yield.
Reﬂectron MALDI-TOF MS of the lipid A fraction was performed, in negative-ion mode, on a 4800
Proteomic analyzer (Applied Biosystems) supplied with a neodymium-doped yttrium aluminum garnet
(Nd:YAG) laser (wavelength, 355 nm, with a 500-ps pulse and a 200-Hz ﬁring rate). External calibration
TABLE 7 Plasmids
Plasmid
Parental
plasmid/replicon Relevant characteristicsa Construction, origin, or reference
pACYC184 pSC101 ori p15A Camr Tetr 90
pACYC184-LptA LptB pACYC184 plac-lptA lptB Camr lptAB genes were excised from plasmid pWSK29-LptA LptB and
subcloned into BamHI-SalI sites of pACYC184.
pCP20 bla cat; thermosensitive
replication
76
pET-LptA41-H pET21a pT7-lptA41-His6 lptA41 allele was PCR ampliﬁed with AP182 and AP183 and cloned
into BamHI-NotI sites of pET-LptA-H.
pET-LptA42-H pET21a pT7-lptA42-His6 Ampr lptA42 was obtained by site-directed mutagenesis with FG3191-
FG3192 primers from pET-LptA41-H as the template.
pET-LptA-H pET21a pT7-lptA-His6 Ampr 27
pGS100 pGZ119EH ptac-TIR cat oriVColD 91
pGS100-OpgH pGS100 ptac-opgH Camr opgH was PCR ampliﬁed with FG3069-FG3070 primers from PS003
genomic DNA and cloned into XbaI-PstI sites of pGS100.
pGS100-OpgH103 pGS100 ptac-opgH103 Camr opgH103 was PCR ampliﬁed with FG3069-FG3070 primers from PS003
genomic DNA and cloned into XbaI-PstI sites of pGS100.
pGS100-MlaA pGS100 ptac-mlaA Camr mlaA was PCR ampliﬁed with FG3067-FG3068 primers from PS003
genomic DNA and cloned into XbaI-PstI sites of pGS100.
pGS100-MlaA102 pGS100 ptac-mlaA102 Camr mlaA102 was PCR ampliﬁed with FG3067-FG3068 primers from PS102
genomic DNA and cloned into XbaI-PstI sites of pGS100.
pGS103 pGS100 ptac-lptC Camr 91
pGS108 pGS100 ptac-lptC-His6 cat oriVColD 16
pKD3 oriR Ampr Camr; source of cat
cassette
76
pKD4 oriR Ampr Kanr; source of kan
cassette
76
pKD46 oriR101 repA101ts araC araBp-
red bla
76
pWSK29 pBSIISK pSC101 ori f1 ori lacZa Ampr 92
pWSK29-LptA LptB pWSK29 plac-lptA41 lptB Ampr 93
pWSK29-LptA36 LptB pWSK29-LptA
LptB
plac-lptAI36A I38A lptB Ampr By site-directed mutagenesis with primers AP184-AP185
pWSK29-LptA37 LptB pWSK29-LptA36
LptB
plac-lptA36R76D lptB Ampr By site-directed mutagenesis with primers AP112-AP113
pWSK29-LptA41 LptB pWSK29-LptA37
LptB
plac-lptA37K83D lptB Ampr By site-directed mutagenesis with primers AP186-AP187
pWSK29-LptA42 LptB pWSK29-LptA41
LptB
plac-lptA41M112I lptB Ampr Spontaneous mutant
aCam, chloramphenicol.
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was performed using the ABSciex peptide calibration mixture, and mass accuracy was better than 50
ppm. The matrix solution was prepared by dissolving 2,4,6-trihydroxyacetophenone (THAP) in CH3OH-
0.1% triﬂuoroacetic acid (TFA)-CH3CN (7:2:1 [vol/vol/vol]) at a concentration of 75 mg/ml. A sample-
matrix solution mixture (1:1 [vol/vol]) was deposited (1 l) onto a stainless-steel sample MALDI probe tip
and dried at room temperature.
Afﬁnity puriﬁcation of membrane Lpt complexes. Membrane Lpt complexes were afﬁnity puriﬁed
from strains expressing His-tagged LptC from pGS108 plasmids as previously described (23, 33) with a
few modiﬁcations. Cells were lysed by a single cycle through a cell disruptor (One Shot model; Constant
Systems Ltd.) at a pressure of 22,000 lb/in2, and the membranes were collected by ultracentrifugation of
the supernatant at 100,000  g for 2 h. The membranes were extracted at 4°C for 30 min with 5 ml of
50 mM Tris-HCl, pH 7.4, 10% glycerol, 1% dodecyl -D-maltoside (DDM) (Sigma-Aldrich), and 5 mMMgCl2.
The mixture was centrifuged again at 100,000  g for 1 h, and insoluble material was discarded. The
supernatant was incubated with 0.5 ml Talon resin suspension for 20 min at 4°C, and the mixture was
then loaded onto a column, washed with 10 ml of 50 mM Tris-HCl, pH 7.4, 10% glycerol, 0.05% DDM, 20
mM imidazole, and eluted with 5 ml of 50 mM Tris-HCl, pH 7.4, 10% glycerol, 0.05% DDM, and 200 mM
imidazole. The eluate was concentrated using an ultraﬁltration device with a 10,000-Da cutoff (Vivaspin;
GE Healthcare) by centrifugation at 7,000  g to a ﬁnal volume of 50 l. Samples were mixed with 2
loading buffer, boiled, separated by SDS-12.5% PAGE (85), electroblotted, and immunodetected using
anti-His monoclonal antibodies (1:3,000; Sigma-Aldrich) to detect LptC-H and anti-LptD (1:500) and
anti-LptF (1:3,000; GenScript Corporation) and anti-LptB (1:10,000; kindly provided by D. Kahne and N.
TABLE 8 Oligonucleotides
Name Sequencea Notes
AP54 cgagaggaattcaccATGAGTAAAGCCAGACGTTGGG ΔlptAB::kan cassette for EM004 construction by three-step PCR,
with AP268; EcoRI
AP79 GTGTAGGCTGGAGCTGCTTCG Ampliﬁcation kan cassette from pKD4, with AP80
AP80 CATATGAATATCCTCCTTAG Ampliﬁcation kan cassette from pKD4, with AP79
AP112 CAAAGTGGTCGTTACCGATCCGGGCGGCGAACAAGG pWSK29-LptA41 LptB (R76D) construction, with AP113
AP113 CCTTGTTCGCCGCCCGGATCGGTAACGACCACTTTG pWSK29-LptA41 LptB (R76D) construction, with AP112
AP182 ctcgacgcggccgcTATATACCCTTCTTCTGTG pET-LptA41-H construction, with AP183; NotI
AP183 cgagatggatccATGAAATTCAAAACAAACAAAC pET-LptA41-H construction, with AP182; BamHI
AP184 CACTGATCAGCCGGCCCACGCTGAATCGGACCAG pWSK29-LptA41 LptB (I36A and I38A) construction, with AP185
AP185 CTGGTCCGATTCAGCGTGGGCCGGCTGATCAGTG pWSK29-LptA41 LptB (I36A and I38A) construction, with AP184
AP186 GCGGCGAACAAGGTGATGAAGTGATTGACGGC pWSK29-LptA41 LptB (K83D) construction, with AP187
AP187 GCCGTCAATCACTTCATCACCTTGTTCGCCGC pWSK29-LptA41 LptB (K83D) construction, with AP186
AP266 ctaaggaggatattcatatgGATAGGGTAGAAGTTTGCG ΔlptAB::kan cassette construction; kan hybrid primer for EM004
construction by three-step PCR, with AP267
AP267 CTAATGATCAGTCTGGCCTC ΔlptAB::kan cassette for EM004 construction by three-step PCR,
with AP266
AP268 gaagcagctccagcctacacGATTAAGGCTGAGTTTG ΔlptAB::kan cassette construction; kan hybrid primer for EM004
construction by three-step PCR, with AP54
AP354 GTCATGGATGGCAAACTG mlaA102-SPA::kan cassette construction; SPA-kan hybrid primer
for EM002 construction by three-step PCR, with AP403
AP387 TCCATGGAAAAGAGAAG Ampliﬁcation of SPA::kan cassette from CAG60297, with AP388
AP388 CATATGAATATCCTCCTTAG Ampliﬁcation of SPA::kan cassette from CAG60297, with AP387
AP400 GGTATCGACAACCAAGAACC mlaA102-SPA::kan cassette construction for EM002 construction
by three-step PCR, with AP404
AP403 catcttctcttttccatggaTTCAGAATCAATATCTTTTAAATC mlaA102-SPA::kan cassette construction; SPA-kan hybrid primer
for EM002 construction by three-step PCR, with AP354
AP404 ctaaggaggatattcatatgGAAACAAATAAAAAAGGTG mlaA102-SPA::kan cassette construction; SPA-kan hybrid primer
for EM002 construction by three-step PCR, with AP400
FG3067 cgactagtctagaATGAAGCTTCGCCTGTC pGS100-MlaA and pGS100-MlaA102 construction, with
FG3068; XbaI
FG3068 cgagatctgcagTTATTCAGAATCAATATC pGS100-MlaA and pGS100-MlaA102 construction, with
FG3067; PstI
FG3069 cgactagtctagaATGAATAAGACAACTGAGTAC pGS100-OpgH and pGS100-OpgH103 construction, with
FG3070; XbaI
FG3070 cgagatctgcagTTATTGCGAAGCCGCATC pGS100-OpgH and pGS100-OpgH103 construction, with
FG3069; PstI
FG3116 gtgaaacctggagctaccagttacctgccaatgaataagGTGTAGGCTGGAGCTGCTTC ΔopgH::cat cassette construction, with FG3117
FG3117 gtaggcctgataagcgtagcgcatcaggcaactacgttttCATATGAATATCCTCCTTAG ΔopgH::cat cassette construction, with FG3116
FG3153 catcgttaatctctatggtgcaacgcttttcagatatcacGTGTAGGCTGGAGCTGCTTC ΔwcaJ::cat cassette construction, with FG3154
FG3154 caggaaaacgattttgatatcgaaccagacgctccattcgCATATGAATATCCTCCTTAG ΔwcaJ::cat cassette construction, with FG3153
FG3191 GTCACGCTTCCCAGATTCACTACGAACTGGC pET-LptA42-H construction, with FG3192
FG3192 GCCAGTTCGTAGTGAATCTGGGAAGCGTGAC pET-LptA42-H construction, with FG3191
aUppercase letters, sequence present in the template; lowercase letters, additional/modiﬁed sequence not present in the template; boldface letters, codons mutated
by site-directed mutagenesis. Restriction sites are underlined.
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Ruiz) sera to detect the cognate proteins. For LptA detection, samples were fractionated by 15% Tricine
SDS-PAGE and immunodetected using a 1:1,000 dilution of anti-LptA serum (GenScript Corporation). As
secondary antibodies, goat anti-rabbit and anti-mouse immunoglobulins (Li-Cor) were used at a dilution
of 1:15,000.
Protein expression and puriﬁcation. Cultures of E. coli strain BL21(DE3) carrying the pET vector
expressing full-length LptA or LptA mutant proteins fused to a C-terminal tag (SGRVEH6) (27) were grown
in M9 minimal medium to an OD600 of 0.6 at 30°C. Expression was induced by the addition of 0.5 mM
IPTG (Sigma-Aldrich) and further incubation for 16 to 18 h at 20°C. Cells were harvested by centrifugation
at 4°C (5,000  g; 20 min). The cell pellets were resuspended in buffer A (50 mM sodium phosphate, pH
8.0, 300 mM NaCl, 10 mM imidazole, 10% glycerol), followed by 30 min incubation at 4°C with shaking
in the presence of lysozyme (1 mg/ml), DNase (100 g/ml), 10 mM MgCl2, and 1 mM phenylmethane-
sulfonyl ﬂuoride (PMSF) (Sigma-Aldrich). The cells were disrupted as described above. Unbroken cells
and cell debris were removed by centrifugation at 4°C (39,000  g; 30 min). The soluble proteins
were puriﬁed from the supernatant with Ni-nitrilotriacetic acid (Ni-NTA) afﬁnity columns (Qiagen).
The columns were washed with 10 column volumes (CV) of 4% buffer B (50 mM sodium phosphate,
pH 8.0, 300 mM NaCl, 500 mM imidazole, 10% glycerol) in buffer A. Proteins were eluted by a 10%,
20%, 50%, 70%, and 100% buffer B stepwise gradient, at 1 CV per step. Fractions were analyzed by
SDS-12.5% PAGE. Pooled fractions containing the puriﬁed protein were dialyzed against 20 mM
Tris-HCl, pH 7.4, and 300 mM NaCl through cellulose membranes (10,000-Da cutoff; Sigma-Aldrich).
The protein concentration was determined with a Coomassie (Bradford) assay kit (Thermo-Pierce),
using bovine serum albumin as a standard.
LPS binding assay. The in vitro LPS binding assay was based on a protocol described previously (40),
with minor modiﬁcations. Brieﬂy, assays (500 l) were carried out in buffer C (50 mM sodium phosphate,
pH 8, 50 mM NaCl) containing 25 M puriﬁed His-tagged protein and a 5-fold molar excess of puriﬁed
smooth LPS from E. coli serotype O55:B5 (Sigma-Aldrich; assumed mass, 10,000 Da). The reaction
mixtures were incubated at room temperature for 1 h on a rotary shaker to allow the formation of
LPS-protein complexes. Ni-NTA resin (200 l; His-Select nickel afﬁnity gel; Sigma-Aldrich), washed in 1 ml
of buffer C, was added to the reaction mixtures and incubated for another hour to allow binding of
the LPS-protein complexes. The reaction mixture was centrifuged at 13,000  g for 1 min, and the
supernatant (ﬂowthrough [FT]) was collected. The resin was then washed four times with buffer C, and
the protein-LPS complexes were eluted in two steps, with 500 l of buffer C containing 300 mM
imidazole (elution 1 [E1]) or 500 mM imidazole (E2), respectively. To monitor LPS-LptA complex
formation, equal volumes (20 l) of the collected chromatographic fractions were analyzed by denatur-
ing gel electrophoresis. For LPS visualization, samples were fractionated by 18% Tricine SDS-PAGE (86)
and immunodetected using a 1:3,000 dilution of the anti-LPS core WN1 222-5 monoclonal antibodies
(HyCult Biotechnology b.v.). LptA was analyzed by SDS-12.5% PAGE and immunodetected using a 1:3,000
dilution of the anti-His monoclonal antibodies (Sigma-Aldrich).
Membrane fractionation. IMs and OMs were separated by isopycnic sucrose gradient centrifugation
as described previously (33). Proteins were separated by SDS-12.5% PAGE, followed by Coomassie blue
staining to determine the porin proﬁle, or immunoblotted using anti-LamB (a kind gift from T. J. Silhavy).
This antibody cross-reacts with OmpA, LptD (GenScript Corporation), and LptB antibodies (kindly
provided by N. Ruiz and D. Khane). For the LPS proﬁle, fractions were analyzed by 18% Tricine SDS-PAGE
and immunoblotted using anti-LPS WN1 222-5 monoclonal antibodies.
OM vesicle preparation. OM vesicle isolation was performed as previously described (44). Brieﬂy, for
whole-cell lysate control samples, 1 ml of culture was collected and resuspended in a volume (in
milliliters) of SDS sample buffer equal to 1/8 of the total OD of the sample. For OMV preparation, a total
amount of 16 OD was pelleted (5,000  g; 10 min; 4°C). Equal volumes of the culture supernatants were
ﬁltered through 0.22-m ﬁlters to retain whole cells. OM vesicles were isolated and concentrated from
the ﬁltered supernatants by ﬁltration through an Amicon Ultra-4 100K centrifugal ﬁlter (Millipore).
Samples were resuspended from the 100K ﬁlter in 50 l of SDS sample buffer. Whole-cell lysate and OM
vesicle samples were boiled for 10 min, resolved by SDS-12.5% PAGE, and immunoblotted. Monoclonal
antibodies against MBP (Thermo Fisher) were used at a dilution of 1:2,000, whereas polyclonal sera
against LptE, LptB, and LamB (kindly provided by D. Khane, N. Ruiz, and T. J. Silhavy) were used at
dilutions of 1:5,000, 1:10,000, and 1:5,000, respectively. As secondary antibodies, anti-goat, anti-rabbit,
and anti-mouse immunoglobulins (Li-Cor) were used at a dilution of 1:15,000.
Determination of protein release in cell supernatants. Equal amounts of cells were collected for
5 min at 16,000  g. The pellets were resuspended in SDS sample buffer and boiled for 10 min. Cell-free
supernatants were obtained by ﬁltration through a 0.22-m ﬁlter (Millipore), subsequently 20-fold
concentrated with trichloroacetic acid, and boiled for 10 min. Protein samples were separated by
SDS-12.5% PAGE and stained with Coomassie blue.
Microscopy. Cells grown to an OD600 of 0.3 were ﬁxed with 1.8% formaldehyde and 0.03%
glutaraldehyde in PBS and incubated for 30 min at 30°C, with shaking. Cells were then harvested, washed
with PBS, and resuspended in 0.4 ml of PBS. A cell suspension (5 l) was spotted onto a microscope slide
coated with a thin layer of 1% agarose. Images were acquired with a Zeiss Axiovert 200M microscope
coupled with an AxioCam Mrm device camera (Zeiss) and with Metamorph imaging software (Universal
Imaging). For membrane staining, cells were mounted on a slide coated with 1% agarose supplemented
with the membrane dye FM5-95 (ThermoFisher) to a ﬁnal concentration of 2 g/ml. Images were
analyzed with ImageJ (http://rsb.info.nih.gov/ij/).
Accession number(s). The genomic data are available in the Sequence Read Archive (SRA) (http://
www.ncbi.nlm.nih.gov/sra), accession number PRJNA345432.
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